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41 PREFACE
This thesis reports a research project that addressed different aspects of sciatica. It was carried 
out at the Rheumatology Department at Sykehuset Østfold, in co-operation with my 
colleague, Dr Anne Julsrud Haugen. The Back Clinic at the Rheumatology Department 
investigates and treats about 1,700 outpatients and 250 inpatients per year, a large proportion
of whom suffer from sciatica. In caring for sciatica patients, we realized that the existing 
literature was inadequate in informing patients and doctors about the prognosis of sciatica in 
terms of pain, disability, and work. This inspired us to establish a prospective cohort study in 
collaboration with the Back Clinics at Sørlandet Sykehus, Ullevål Universitetssykehus, and 
Sykehuset Innlandet. We both participated in the preparation of the protocol and in the 
collection and analysis of the data, and we were supervised together. Unfortunately, illness 
prevented me from undertaking the training component of the university’s normal PhD 
programme. Instead, I have applied for the academic degree of dr.philos.
This research has culminated in Anne’s dissertation “Sciatica and Disc Herniation. 
Outcome Measures and Prognostic Factors” and the present thesis. Because of the 
interrelatedness of our work, we suggest that those interested in this topic should read both
theses together.
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aground. She phoned me daily with updates, giving me invaluable support and 
encouragement. After countless talks and discussions, we have both moved forward in the 
intellectual and practical labyrinth of research.
Our co-authors and supervisors have contributed greatly to this work. They have given
generously of their time and expertise to nurture two research novices. Comments, advice,
and corrections have been given, and extremely fruitful and inspiring discussions have taken 
place. We were very fortunate that Margreth Grotle (principal supervisor), Bård Natvig, and 
5Jens Ivar Brox (co-supervisors), and Anne Keller took a chance on us. They have contributed 
their great experience, insight, and patience.
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Ihlebæk provided the general population data set used to analyse the subjective health 
complaints and co-authored paper III. Eli Minge did an excellent job distributing more than 
2,000 large questionnaires to the right patients at the right time and collecting the data.
We extend special thanks to Prof. Leiv Sandvik, who introduced us to the interesting 
world of medical statistics. Leiv explained the general principles as well as how to perform 
each of the analyses. We have come to understand that statistics is not an exact science, but 
requires judgement and qualified decisionsas does medicine.
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Eriksen, then in charge of the research network for back pain at the University of Bergen. 
They invited us to the “Geilo meetings” where we made contact with other colleagues 
interested in back pain research.
The Research Department at Sykehuset Østfold has been very supportive. Special 
thanks go to Famara Sanyang, Marianne Eckhoff, and Morten Jacobsen. The staff at the 
Medical Library have provided innumerable articles and excellent service.
We also wish to thank our colleagues at the Rheumatology Department for including 
patients and for their consideration of this research, despite busy days of clinical work. We 
especially thank Bjørn Finnanger, Jonas Berglund and Grete Jespersen.
I am endlessly grateful to my wife Nina for her untiring support, especially during my 
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85 INTRODUCTION
5.1 The sciatica concept
The word ‘sciatica’ is derived from the Greek word ischión meaning hip-joint and the Latin 
word ischiadicus meaning hip pain. In the 18th century, sciatic nerve pain was differentiated 
from arthritic hip pain1 and thereafter, ‘sciatica’ became the established term for pain 
radiating from the lower back or buttock into the leg. About 90% of cases of sciatica are 
caused by a herniated intervertebral disc in the lumbar column. Other lesions affecting the 
integrity of the lumbo-sacral nerve roots (L4–S3) or the sciatic nerve may produce the same 
clinical picture, including lumbar canal or foraminal stenosis, tumours, cysts, haemorrhage, 
abscesses, fractures, and some less common conditions.
‘Sciatica’ is the most commonly used term in the literature, but ‘lumbar disc 
syndrome’, ‘lumbar disc protrusion causing radiculopathy’, and ‘lumbo-sacral radicular 
syndrome’ are also used. In addition to back and leg pain, muscle weakness and sensory 
disturbances may occur. The condition can vary from short, single episodes to a remitting or 
permanent course over months or years. A rare but potentially devastating complication is 
cauda equina syndrome2, involving impaired bladder, bowel, and genital dysfunction caused 
by the involvement of multiple sacral and lumbar nerve roots.
This thesis focuses on patients with radiating pain and neurological symptoms caused 
by a lumbar disc herniation. We have chosen to use the term ‘sciatica’ because this is the term 
most commonly used in both the scientific literature and daily clinical practice.
5.2 Epidemiology
No epidemiological studies of sciatica in the general population based on radiological 
findings have been published. Therefore, the exact incidence or prevalence rates are unknown. 
However, studies of the general population have estimated the occurrence of sciatica based on 
symptoms and clinical examinations. For example, in a study of the general Finnish 
population, the point prevalence of sciatica was estimated to be 4.8%3. In another 
epidemiological study based on clinical diagnoses made by physicians, the lifetime 
cumulative incidence was estimated to be 12.2%4. In other studies, questionnaires or 
interviews have been used to define cases of sciatica4-7. The use of a wide spectrum of 
definitions of sciatica has resulted in large variations in prevalence estimates7. The one-year 
incidence of cauda equina syndrome is believed to be 1–3/100,000 persons8.
9In Norway, a diagnosis of low back pain accounted for approximately 13% of all 
patients on sick leave and 17% of all compensation days in 1995/19969. Of these claimants,
30% had radiating pain. In a general working population in Sweden10, approximately 5% 
sought health care for a new episode of low back pain during a three-year period, and 25% of 
these suffered radiating pain below the knee and had a positive straight leg raising test. 
Compared with patients with non-specific low back pain, patients with radiating pain 
generally report more severe pain, have longer absences, and lower rates of return to work9, 11-
15. Because of the high social and economic burdens imposed by sciatica, it would be useful to 
be able to identify those workers who are at high risk of continued occupational disability9, 15, 
16.
5.3 Pathoanatomy and pathophysiology
The disc is composed of a central core, the ‘nucleus pulposus’, which is surrounded by a thick 
outer ring of fibrous cartilage, called the ‘annulus fibrosus’. Through the years, the annulus 
becomes stiffer and weaker17, followed by the appearance of nuclear clefts and annular tears18
that permit the gelatinous tissue of the nucleus to be displaced into the annulus, forming 
herniations. Disc herniations can range from protrusions (when the outer annular lamellae 
remain intact) to extrusions (when the annular lamellae are ruptured) to sequestrations (in 
which the herniation is completely detached from the body of the disc)19. Studies of twins 
have shown a substantial genetic predisposition to disc degeneration20.
Within the cauda equina, the nerves run downwards and laterally before exiting their 
respective foramina. At their emergence from the dural sac, the sciatic nerve roots are 
fastened by ligamentous attachments to the vertebral body and the subjacent pedicle within 
the foramen. Therefore, a disc herniation may cause stretching and compression of the nerve 
root and dorsal root ganglion. A posterior lumbar disc herniation usually affects the root of 
the nerve exiting at the level below the herniation, i.e., a herniation between the L5 and S1
vertebrae will usually affect the S1 nerve root. Herniations extending far laterally may affect 
the root at the same level and large herniations may affect more than one nerve.
It has been shown that the stimulation of compressed roots causes pain, whereas the 
manipulation of normal roots does not21. Rydevik22 and Olmarker23 have reported that 
compression was associated with the formation of oedema and reduced the propagation of 
electrical impulses in the nerve root. They also showed that the application of tissue from the 
nucleus pulposus to the root induced inflammatory reactions24. A histological evaluation of 
herniated disc tissue revealed prominent infiltration of inflammatory cells, most markedly 
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macrophages and cytokines. Cytokines promote lymphocyte activation, which further recruits
macrophages and activates them to phagocytosis and the secretion of proteolytic enzymes25. 
The combination of compression and inflammation is now widely accepted as an essential
pathophysiological factor in sciatica26, 27. Long-standing root compression may result in axon 
loss and intra- and extraneural fibrosis. All types of fibres in the nerve roots may be affected.
Longitudinal magnetic resonance imaging (MRI) studies have indicated a reduction in 
the size of symptomatic herniations over time, especially extrusions and sequestrations28-30. 
The resorption of the herniated disc material is thought to result from the inflammatory 
process via macrophage activation and phagocytosis31.
MRI examinations of people without back pain commonly show disc bulges and 
protrusions; whereas extrusions and sequestrations are rare32. The prevalence of clinically 
silent herniations has been reported to be about 20%–30%32-34. Why some herniations 
produce symptoms and others do not is not well understood. Therefore, we clearly must 
extend our knowledge of the pathoanatomy and pathophysiology of sciatica.
5.4 Diagnosis and assessment
Diagnosing sciatica caused by lumbar disc herniation relies on history taking, a physical 
examination, and imaging. However, the weak associations between MRI findings and self-
reported symptoms35, 36 mean that diagnosis is not always a straightforward process. The 
clinical assessment of sciatica often reveals a complexity of self-reported symptoms and 
disability, together with other subjective health complaints (SHCs).
5.4.1 Physical examination and imaging
Physical examination and imaging focus on identifying the anatomical structure involved. The 
symptoms of sciatica include radiating pain with or without sensory disturbance or weakness. 
The pain is typically described as ‘sharp’, ‘lancinating’, or ‘burning’ and is often exacerbated 
by coughing or sneezing. Clinical signs of nerve dysfunction support the diagnosis. Such 
signs include an abnormal straight leg raising test and reduced dermatomal sensibility, 
muscular strength, or tendon reflexes. The examination of a patient suspected of cauda equina 
syndrome includes testing both the bladder and anal functions.
A diagnosis of sciatica (caused by disc herniation) requires the identification of the
herniation on MRI or computed tomography (CT) at a site and level corresponding to the 
symptoms and clinical findings. CT and MRI show equal capacities to identify lumbar disc 
herniations37, 38 and can classify them according to morphology, volume, or location in the 
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sagittal or horizontal plane19. However, the associations between self-reported symptoms, the 
size of the herniation, and whether it is a protrusion, extrusion, or sequestration are weak35, 36. 
Electrophysiological tests do not provide diagnostic information beyond that obtained from 
the history, the imaging results, and the clinical examination39.
Although guidelines for the classification of disc abnormalities exist19, they are not 
always followed in clinical practice. Radiologists vary according to their interests and 
experience, and images vary in how technically demanding they are to interpret. Therefore, 
potential disc pathology based on MRI or CT images may be described differently by 
different radiologists. These factors influence the diagnosis of sciatica and therefore may 
affect both the care of the individual patient and the selection of patients for research 
purposes.
5.4.2 Symptoms and disability
There exists no consensus on the exact symptoms that must be present or the outcome that 
should be used for the diagnosis of sciatica. When planning the current study, no sciatica-
specific questionnaires for Norwegian-speaking patients existed. Clinical research on sciatica 
has generally been performed with outcome measures intended for patients with low back 
pain, with a supplement addressing leg pain intensity40, 41. In 1995 and 2003, as part of the
large observational Maine Lumbar Spine Study42, three sciatica-specific instruments were 
introduced. These included the Sciatica Bothersomeness Index (SBI), the Sciatica Frequency 
Index (SFI)43, and the Maine–Seattle Back Questionnaire (MSBQ)44.
The SBI and SFI both address four sciatica symptoms: 1) leg pain; 2) numbness or 
tingling in the leg, foot, or groin; 3) weakness in the leg/foot; and 4) back or leg pain while 
sitting. Each scale produces a total score by summing the scores across the four symptoms. 
They also provide an opportunity to investigate each symptom using a standardized 
methodology.
The 12-item MSBQ is an abbreviated version of the Patrick-modified 23-item 
Roland–Morris Disability Questionnaire43, 45 designed for patients with sciatica and lumbar 
spinal stenosis. It represents an attempt to minimize the respondent burden associated with the 
longer 23-item version.
However, the validity, reliability, and responsiveness of the three measures have not 
been replicated outside the Maine Lumbar Spine Study. By using the MSBQ and the two 
sciatica indices in the present study, we could exploit the opportunity to compare our results 
with the results of the Maine Study.
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5.5 Comorbid subjective health complaints
Among patients who present with low back pain, probably as many as 90% will have non-
specific symptoms, defined as symptoms without a clear specific cause5. Several studies have 
shown that patients who develop chronic non-specific low back pain report high rates of 
coexisting mental and physical conditions46-48. Many of these conditions represent SHCs,
such as headache, muscular pain, dyspnoea, gastrointestinal discomfort, anxiety, and sadness,
and several are referred to as unexplained, functional, or somatization symptoms49-51. 
However, whether this elevated comorbidity is a cause, an effect, or just a concomitant
phenomenon of chronic low back pain is unknown. It has been suggested that patients with
chronic low back pain represent a generally frail subgroup of people predisposed to 
developing chronic pain52 and/or symptoms of somatization53. Most of the relevant research 
has either focused on patients with non-specific chronic low back pain or has not 
distinguished between patients with specific and non-specific back pain. This distinction may 
be important because the mechanisms underlying the corresponding comorbidity might differ. 
Sciatica caused by a lumbar disc herniation represents the most common cause of specific low 
back pain. To our knowledge, the only study to report comorbidity in sciatica was a Finnish 
population study that showed a weak association with cardio-vascular, respiratory, mental 
diseases, and some musculoskeletal conditions54.
The majority of research in this field has so far been cross-sectional; few prospective 
studies exist52. Therefore, knowledge of the comorbid health complaints in a well-defined 
longitudinal cohort of patients with sciatica might offer more insight into the issue of 
comorbidity in back pain. Comparing the prevalence of other health complaints in a cohort of
sciatica patients with that in the general population may also provide useful information. A
higher prevalence in sciatica patients than in the general population might suggest that these 
symptoms are secondary to sciatic pain and disability. Exploring this topic was one of the 
main intentions of the present study.
5.6 Treatment
The usual treatment for sciatica consists of pain-relieving medications. Many patients also
receive physical therapy, perform exercises, etc. However, no conservative therapies, such as
bed rest, traction, manipulation, etc., have been shown to affect the long-term prognosis55. 
Non-steroidal anti-inflammatory drugs56 and the systemic or epidural administration of 
glucocorticosteroids have shown conflicting or negative results in randomized trials57-59.
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Biological agents that target tumor necrosis factor , a cytokine involved in the inflammatory 
process, have also been disappointing60-62. Chemonucleolysis, the intradiscal injection of a 
proteolytic enzyme, was only slightly more effective than a placebo63, 64, but less effective 
than discectomy, and is no longer commercially available.
During the last 80 years, the surgical removal of the herniated disc material has 
become an increasingly popular procedure1. About six operations per 10,000 inhabitants are 
performed in Norway each year65. However, despite its popularity, the effect of surgical 
therapy has not been firmly established.
When the present study was planned, only one randomized study of the effect of 
surgical therapy had been performed. In a landmark Norwegian study commenced in 197066, 
Weber randomized patients with uncertain indications for surgery to either treatment with 
conservative care or surgery. One-quarter of the patients in the conservative group were 
treated surgically during the first year. At the one-year follow-up, 87% of the surgical and 
82% of the non-surgical patients reported a good or fair result. At the four- and 10-year
follow-ups, about 90% of the patients in both groups reported a good or fair result. The results 
of the few other randomized trials that have been performed67-69 have been difficult to 
interpret because of non-adherence to the assigned treatment groups. In the SPORT trial69,
only 60% of those who had initially been randomized to surgery were actually operated on, 
whereas 45% of those assigned to conservative therapy underwent surgery. Significant 
advantages of surgery were found in the as-treated analysis but not in the intention-to-treat 
analysis. Currently, surgical discectomy is considered to relieve acute pain and pain-related 
disability in the short term (i.e., for some months), but does not seem to improve the long-
term prognosis70, 71.
5.7 Sciatica and occupational disability
Despite the social and economic burdens of sciatica, surprisingly little is known about the 
prognostic factors for occupational disability. Two papers, one originating from the SPORT 
study72, 73 and one from the Maine Lumbar Spine Study74, have dealt with the prognosis for
returning to work. Their main focus was the effect of the workers’ compensation status of the 
patients. In neither study was the patient’s workers’ compensation status significantly related 
to his/her return to work at the two- or four-year follow-up, respectively. The results of the 
multivariate analysis in the Maine Study indicated that younger age, better self-perception of 
general health, and less severe low back pain at baseline were associated with higher rates of 
return to work at four years74. Certain psychological factors, such as anxiety, depression, and 
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pain-related fear, have been associated with occupational disability in patients with non-
specific low back pain75, but their roles in sciatica have not been established76, 77.
A few authors have investigated the factors predicting work-related outcomes in 
patients treated surgically78. In a Norwegian study, Graver et al.77 reported that female sex, 
short height, a long period of sickness absence, and physically strenuous work reduced the 
likelihood of returning to work one year after surgery. Donceel and Du Bois79 found that pain-
related disability, depression, somatization, recent life events, and the patient’s own 
prediction were associated with the capacity to work at the one-year follow-up, as assessed by 
the physicians in a sickness benefits fund. In a small study, Schade et al.76 reported that
preoperative pain level, depression, and occupational mental stress predicted self-reported
return to work two years after surgery. A Finnish study80 indicated that when the patients’ 
prognostic factors were assessed two months after the operation, leg pain, pain-related 
disability, and poor motivation for work were related to the number of self-reported sickness 
absences.
In planning the present study, it became obvious that more research is required into
occupational disability in sciatica patients. Among several outcomes related to occupational 
disability, the time to return to work (time lost) and working/not working are important
factors. The first can be used as an indicator of the cost of the illness and the second as an 
indicator of chronicity15, 81. In this study, we intended to use patient-reported data, but the 
validity of self-reported sickness absence data is not well established. The few studies that 
have compared sickness absence data obtained by self-report with data obtained from a
register have only been performed in occupational82-90 or general population settings91, with 
few occurrences and short absences. Data obtained in such settings might not be applicable to 
clinical settings with high absence rates, like those of the sciatica patients in the present study.
Therefore, before self-reported sickness absence data are used as an outcome measure, their
validity in a clinical hospital setting must be investigated more thoroughly.
Because all Norwegians are covered by the National Sickness Benefit Register
(NSBR), it seemed sensible to start by comparing self-reported data with data obtained from
this register.
To qualify for sickness benefits in Norway, occupational disability must be 
documented with a doctor’s sick leave certificate, which is submitted to the NSBR. If the 
person is still unable to work after one year, he or she may be entitled to a rehabilitation 
allowance or disability benefits. Employees can also certify themselves sick up to four periods
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a year, with each absence comprising a maximum of three consecutive days. Self-certified 
absence is not registered by the NSBR.
6 RESEARCH AIMS
The general aim was to assess self-reported symptoms, health complaints, and return to work 
in patients with sciatica and disc herniation. The specific aims were:
1. To translate, culturally adapt, and test the measurement properties of three self-reported 
outcome measures especially designed for patients with sciatica (paper I).
2. To investigate how sciatica patients rate the severity of their sensory disturbances and 
muscle weakness relative to their pain (paper II).
3. To test the hypothesis that the occurrence of subjective health complaints among patients 
with sciatica is higher than in the normal population and to determine whether a change in the 
severity of sciatica is associated with a corresponding change in the number of subjective 
health complaints (paper III).
4. To investigate how well sickness absence data obtained by self-report agree with data from 
a public registry (paper IV).
5. To identify prognostic factors for return to work during a two-year follow-up (paper V).
7 MATERIALS AND METHODS
7.1 Designs
The present thesis is based on data from a multicentre, observational cohort study. In paper I,
we used a cross-sectional test–retest design. In paper II, we used the baseline data in a cross-
sectional design. In paper III, both a cross-sectional and a longitudinal design were used: first,
the baseline data from the patient cohort were compared with a historical sample from the 
general population in a case–control study; and second, the longitudinal data from the patient 
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cohort up until the one-year follow-up were used. In papers IV and V, we used longitudinal 
data from the cohort study. Table 1 shows the sources of the data that were used in each of the 
papers.
Table 1. Data sources according to paper.
Data source
Patient cohort General 
population
sample
National 
Sickness 
Benefit 
RegisterBaseline 3 months 6 months 1 year 2 years
Paper I 
Paper II 
Paper III    
Paper IV      
Paper V   
7.2 Study samples
7.2.1 Patients
All patient data were obtained from a prospective cohort study with a two-year follow-up
period, from patients with sciatica and disc herniation referred to the back clinics at four 
hospitals in south-eastern Norway (Sykehuset Østfold, Sørlandet Sykehus, Ullevaal 
Universitetssykehus, and Sykehuset Innlandet). From January 2005 to December 2006, a total 
of 466 patients with a mean age of 43.6 years (range 18.0–78.3 years) was enrolled, 42.5% of 
whom were women.
The patients included were 18 years of age or older, had radiating pain or paresis 
below the knee, and an ipsilateral lumbar disc herniation at the corresponding level verified 
by MRI or CT. The exclusion criteria were pregnancy, spinal fracture, tumour, infection, 
previous surgery to the affected disc, and inability to communicate in written Norwegian. The 
patients were invited to participate in the study by the clinic staff.
7.2.2 General population sample
To compare the occurrence of SHCs in the sciatica patients with that in the general 
population, an historical sample was used of 1,014 persons who had been interviewed by 
17
telephone in 2003 by the opinion poll firm Norwegian Gallup. This data set was provided by 
Camilla Ihlebæk92, one of the co-authors of paper III. To ensure a representative sample of the 
adult Norwegian population, a standard procedure of computer-assisted telephone 
interviewing (random digit dialling) was used. The sample was drawn randomly, using 
telephone numbers in proportion to the population in each municipality, and the respondent in 
each household was selected by interviewing the person who had had the most recent 
birthday, with up to five recalls if the initial attempts were unsuccessful. To ensure
comparability with the age span of the sciatica cohort, respondents aged < 18 years and > 79 
years were excluded from the data set, producing a sample of 928 persons.
7.3 Patient assessment procedure
On the day of inclusion, the participants were given a baseline questionnaire at the clinic, and 
a clinical examination was conducted by a physician or physiotherapist. Follow-ups were 
conducted at three, six, 12, and 24 months thereafter with mailed questionnaires, which were 
completed at home and returned in prepaid envelopes. Patients who had not responded two
weeks after the scheduled date were contacted by telephone or a text message. A reminder 
letter was sent to non-responders if no reply was obtained after three weeks. The follow-up 
assessments included the outcome measures used at baseline and questions about any 
treatment received since the previous follow-up.
To establish the test–retest reliability of the MSBQ, SBI, and SFI, 87 patients at 
Sykehuset Østfold repeated the questionnaires after a two-day interval and returned them by 
mail (paper I).
7.4 Treatment
Study participation did not involve any specific type of intervention; the patients received 
treatment as usual at each centre. Generally, the patients were advised to stay active and use 
pain medications if necessary. In cases of severe symptoms, surgery was performed at the 
discretion of each centre. The date of the operation was recorded at the next follow-up.
7.5 Patient-reported outcome measures
7.5.1 Sciatica symptoms (papers I and II)
The SBI and SFI both address four symptoms: (1) leg pain; (2) numbness or tingling in the 
leg, foot, or groin; (3) weakness in the leg/foot; and (4) back or leg pain while sitting. Each 
symptom is scored on a scale from 0 to 6. The SFI scoring categories are not at all, very
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rarely, a few times, about half the time, usually, almost always, and always. The SBI scoring 
categories are 0 (not bothersome), 3 (somewhat bothersome), and 6 (extremely bothersome). 
Each scale provides a total score from 0 to 24 when the individual scores are summed across 
the four symptoms. The indices are intended to measure symptoms that occurred during the 
immediately previous week.
7.5.2 Pain-related disability (paper I)
The MSBQ consists of 12 items that address impairment and activity limitations attributable
to leg or back pain, within the same day. Each item is scored as yes (1) or no (0), yielding a 
range of possible scores from 0 to 12. Higher scores indicate greater disability.
7.5.3 Comorbidity (paper III)
The Subjective Health Complaints Inventory93 is a list of 29 items of common somatic and 
psychological complaints. Respondents are asked to grade the intensity of each complaint 
experienced in the previous month on a four-point scale: not at all (0), a little (1), some (2), 
and severe (3). In this thesis, the responses to each complaint were dichotomized into absent
(0) or present (1, 2, or 3) and the SHC number was calculated by summing all the complaints 
reported as present. Two of the items, low back pain and leg pain during exercise, are closely 
related to sciatica and were excluded, reducing the maximum obtainable SHC number from 
29 to 27.
7.5.4 Sickness absence (paper IV)
At each follow-up, the patients responded to the question: Since the previous follow-up, have 
you been on sick leave (including partial sick leave) or rehabilitation because of back 
pain/sciatica? If yes, state the number of weeks. If less than one week, state 0. Patients were 
not asked to report self-certified sick leave.
7.5.5 Current work status (paper V)
The self-reported current work status included the categories: full-time work, partial sick 
leave, complete sick leave, rehabilitation, disability pension, student, job seeker, old-age
retirement, or homemaker.
7.6. The National Sickness Benefit Register
7.6.1 Sickness absence (paper IV)
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Data obtained from the NSBR included the commencement and cessation dates of sickness 
absence, rehabilitation, and disability benefits. In this thesis, the NSBR’s records of sickness 
absence and rehabilitation allowance were regarded as the reference standard for sickness 
absence. Diagnoses on the sickness absence certificates indicating back pain or sciatica 
according to the International Classification of Primary Care [27] were used: L02 (back 
symptom/complaint), L04 (low back symptom/complaint), L84 (back syndrome without 
radiating pain), and L86 (back syndrome with radiating pain). The duration of sickness 
absence was calculated in full weeks by subtracting the commencement date from the 
cessation date. The end of each follow-up period was defined as the date the questionnaire
was returned by the patient. In cases of more than one absence per follow-up period, the 
durations of all the absences were summed.
7.6.2 Time to sustained return to work (paper V)
For patients who, at the time of inclusion and according to the NSBR, were receiving sickness 
benefits or rehabilitation allowances because of back pain/sciatica, being off the national 
register list was used as a proxy measure for ‘returned to work’. ‘Sustained return to work’
was chosen to avoid misclassifications that might arise from recurrences of sickness 
absence94, 95, and was defined as the number of calendar days from inclusion to the first period 
of >60 days during which no benefits were received from the NSBR.
7.7 Independent variables
The independent variables used in the present study included demographic data, clinical data,
and patient-reported outcomes. A summary of these independent variables is given in Table 2.
The patient-reported outcomes included the work subscale of the Fear-Avoidance 
Beliefs Questionnaire96, 97, which is intended to assess fear avoidance beliefs regarding work 
(here called ‘fear avoidance–work’). Pain-related fear of movement/re-injury was measured 
with a 13-item version of the Tampa Scale for Kinesiophobia98, 99. It has been suggested that 
fear avoidance beliefs are an obstacle to recovery in populations of patients with low back 
pain100.
Emotional distress was assessed with the Hopkins Symptom Check List-25101, which 
includes 10 items that assess anxiety and 15 items that assess depression. Each item has four 
response categories, ranging from not at all (1) to extremely (4), referring to symptoms during 
the immediately previous week. The score is calculated as the sum of all the item scores 
divided by the number of items answered. The usefulness of the Hopkins Symptom Check 
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List-25 as a screening tool has been demonstrated in several settings102-105, and a clinical cut-
off of 1.75 is commonly used to define symptomatic cases102, 106, 107. In Norwegian population 
studies, 14%–20% of females and 8%–9% of males have reported values of  1.75108, 109.
As a measure of the ‘generic’ health status, the SF-36110 was used. Here, ‘generic’
means that it does not target specific disease groups. The SF-36 yields an eight-scale profile
of physical functioning, role limitations attributable to physical problems, bodily pain, general 
health, vitality, social functioning, and role limitations attributable to emotional and mental 
health problems. Each domain is scored from 0 (poor health) to 100 (optimal health). The SF-
36 is useful in comparing general and specific populations, comparing the relative burdens of 
diseases, and differentiating the health benefits produced by different treatments.
Table 2. Summary of independent variables and scoring formats.
Independent variables Scale
Demographic
Age Years
Sex
Married or cohabitant Yes/no
Education Years
Current smoker Yes/no
Duration of current sciatica episode Weeks
Duration of back problems < 1, 1–5, > 5 years
Number of previous sciatica episodes 0, 1, 2, 3–4, 5–10, > 10
Clinical examination findings
Straight leg raising test (< 60°) Normal/abnormal
Sensory (dermatomal light touch) Normal/abnormal
Muscular performance* Normal/abnormal
Reflexes (patellar or Achilles) Normal/abnormal
Patient-reported outcomes
Fear Avoidance Beliefs Questionnaire–work96, 97 0–42
Tampa Scale of Kinesiophobia98, 99 13–52
Emotional distress101, 111† 0–4
Back pain (mm on a visual analogue scale) 0–100 
Leg pain (mm on a visual analogue scale) 0–100 
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Generic health status (SF-36)110‡ 0–100
Use of analgesics Daily, weekly, less than weekly, no use
Use of tranquillizers Daily, weekly, less than weekly, no use
Sciatica global change scale Completely gone, much better, better, a little 
better, no change, a little worse, much worse
* Any of: single limb stance, tiptoe or heel walking, supine knee or ankle flexion/extension, big toe extension.
† Assessed with the Hopkins Symptom Check List-25.
‡ Included subscales of vitality, bodily pain, general health, social functioning, physical functioning, role 
physical, role emotional. Higher values indicate better health.
7.8 Statistics
The sample size calculation for this study was based on the intention to perform a prospective 
cohort study to investigate the impact of approximately 20 prognostic factors on successful or 
unsuccessful outcomes after one and two years. It has been suggested that for prognostic 
studies, at least 10 outcome events are required for each factor studied112. Because there was 
no consensus regarding an optimal definition of ‘outcome events’ for sciatica when this study
was planned, we could not provide a precise sample size estimate a priori. However, based on 
the previous Maine Lumbar Spine Study, we expected that surgical treatment would be 
necessary for 30% of the patients and that 30% of those who were surgically treated and 50% 
of those who were not surgically treated would not experience a successful outcome at one
year113. If 50% of the sample experienced poor outcome events, a sample of 400 patients 
would provide sufficient statistical power to test approximately 20 prognostic factors.
All analyses were performed with different versions of SPSS (SPSS, Inc., Chicago, 
IL). Generally, findings with P values of < 0.05 were regarded as significant. In paper V, 
multivariate models were built by including potential prognostic factors with P values of <
0.2 in the univariate analyses. The statistical methods used in this thesis are presented in 
Table 3.
Table 3. Statistical methods according to purpose and paper.
Method Purpose in the present study Paper
95% limits of agreement114 Provides an interval within which 95% of differences 
between two measurements are expected to lie
I, IV
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Area under the receiver 
operating characteristic
curve115
A measure used to correctly discriminate according 
to the external criterion
I
Bland Altman plot114 Illustrates the agreement between two measures, 
either in a test–retest situation or when comparing 
two methods
I, IV
2 test for trend116 Compares ordered categorical (ordinal) variables in 
two independent samples
II
2 test116 Compares categorical variables in two independent 
samples
II
Cohen’s kappa117 Assesses chance-corrected percentage agreement in a 
2  2 table
IV
Cox’s proportional hazard 
regression analysis118
Assesses the effects of several variables on the time 
to occurrence of a dichotomous variable
V
Cronbach’s alpha119 Assesses the internal consistency, i.e., the 
intercorrelation of items on unidimensional scales
I
Factor analysis120 Assesses the underlying latent factors or dimensions
in a scale or questionnaire
I
Intra-class correlation 
coefficient121
Assesses the test–retest reliability of a questionnaire 
with continuous scores
I
Linear regression120 Determines the contribution of one (univariate) or 
several (multivariate) factors to a single outcome 
with an interval or continuous distribution
II
Logistic regression120 Determines the contribution of one (univariate) or 
several (multivariate) factors to a single, binary 
outcome
III, V
Mann–Whitney U test116 Compares continuous or ordinal variables with non-
normal distributions in two independent samples
I
McNemar’s test116 Compares binary variables in one sample obtained at 
two different time points
III
Nagelkerke R2120 Measures how well the independent variable(s) in a
logistic regression explains the outcome 
V
Paired t test116 Compares observations in one sample obtained at 
two different time points; requires differences to be 
normally distributed
III
Percentage agreement122 Determines the percentage of occasions upon which
two methods agree whether an outcome has occurred 
or not, based on a 2  2 table
IV
R2120 Measures how well the independent variable(s) in a 
linear regression explains the outcome
II
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Receiver operating 
characteristic curve analysis116
A graphical plot of the true positive rate (sensitivity) 
vs the false positive rate (1 – specificity) for an
external binary criterion for each of all possible cut 
points on a continuous scale
I
Spearman’s rho116 Quantifies the association between two variables 
with non-normal distributions by rank correlation
I, III,
IV
Standard error of 
measurement (SEM)123
Assesses measurement error in test–retest reliability 
using an ANOVA repeated-measures procedure
I
Standardized response 
mean124
Measures the responsiveness of a questionnaire by 
calculating the ratio of the mean change to the 
standard deviation of that change
I
Student’s t test116 Compares normally distributed continuous variables 
in two independent samples
II
Variance inflation factor120 Measures multicollinearity, i.e., the effect other 
independent variables have on the standard error of a 
regression coefficient
V
Wilcoxon’s matched pairs 
signed-rank sum test116
Compares observations in one sample obtained at 
two different time points; does not require 
differences to be normally distributed
III
7.9 Ethics
Written informed consent was obtained from all participating patients. The protocol was 
approved by the Regional Committee for Medical Research Ethics and the Ombudsman for 
Privacy in Research at the Norwegian Social Science Data Services.
8 SUMMARIES OF RESULTS
In the first part of the study (paper I), the reliability, validity, and responsiveness of the 
Norwegian versions of the MSBQ, SBI, and SFI in sciatica patients were assessed. We used 
baseline data from 466 patients, 87 of whom participated in a test–retest study. The 
completion time was 1–2 minutes for the MSBQ and 30 seconds for both the SBI and the SFI. 
The intra-class correlation coefficients varied between 0.86 and 0.90. The values for 
Cronbach’s alpha were 0.74, 0.70, and 0.65 for the MSBQ, SBI, and SFI, respectively. The 
measurement errors constituted 26% of the total MSBQ score range, 22% of the SBI score 
range, and 27% of the SFI score range. Compared with the MSBQ, the two sciatica indices
better discriminated the patients with normal clinical findings from those with abnormal ones, 
24
but correlated less strongly with measures of pain and physical functioning. All standardized 
response means were  1.3 and all the areas under the receiver operating characteristic curves
were  0.75.
We then investigated how patients rated the bothersomeness of paraesthesia and 
weakness compared with that of leg pain, and how these symptoms were associated with the 
socio-demographic and clinical characteristics of the patients (paper II). The cross-sectional 
SBI data obtained at baseline from 411 patients with clinical signs of radiculopathy were 
used. The mean scores (standard deviation, SD) were 4.5 (1.5) for leg pain, 3.4 (1.8) for 
paraesthesia, and 2.6 (2.0) for weakness. Women reported approximately 10% higher 
bothersomeness scores for all three symptoms than men. In the multivariate models, more
severe symptoms were associated with lower physical function and higher emotional distress. 
The clinical findings for muscular paresis explained 19% of the variability in self-reported 
weakness; the sensory findings explained 10% of the variability in paraesthesia; and the 
straight leg raising test explained 9% of the variability in leg pain.
To determine whether patients with sciatica report higher rates of SHCs than expected, 
the patients were compared with a historical general population sample (n = 928) (paper III). 
The odds ratios (ORs) for the sciatica patients in reporting SHCs at baseline were 
significantly elevated for 15 of the 27 items compared with the general population sample. 
The mean (SD) number of SHCs was also significantly higher in the patient group (7.5 [4.4])
than in the population sample (5.2 [4.4]; P < 0.01). The number of SHCs decreased to normal 
levels in those patients who fully recovered from their sciatica during the one-year follow-up 
period. Among those with persistent or worsening sciatica, the number of SHCs increased to a 
level almost double that of the general population.
Following an amendment to the protocol, all patients included in the sciatica cohort
after October 2005 (n = 227) gave their consent for us to obtain their sickness absence data 
from the NSBR. To assess how well the sickness absence self-reports agreed with the registry 
data, postal questionnaires covering recall periods of three, six, and 12 months and the data
from the NSBR were used (paper IV). Compared with the registry data, the patients 
overestimated the duration of their sickness absences by 2.4 weeks (95% CI 1.1–3.7) and 3.2 
weeks (95% CI 0.1–6.3) during the three- and six-month recall periods, respectively, and 
underestimated them by 0.8 weeks (95% CI –6.5 to 4.9) during the 12-month recall period. 
The 95% limits of agreement were generally wide, varying from –12.5 to 17.3 weeks for the 
three-month recall period and from –38.8 to 37.2 weeks for the 12-month period. For the 
three-, six-, and 12-month recall periods, 48.1%, 28.8%, and 27.3% of the patients, 
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respectively, reported a sickness absence duration that differed by  1 week from that 
recorded in the registry. The percentage agreement on sickness absence occurrence, i.e.,
whether sickness absence had occurred or not, was > 85% for all three recall periods.
To identify prognostic factors for return to work, two patient samples (A and B) were used 
(paper V). Sample A comprised 237 patients who, at baseline, reported being on partial or 
complete sick leave, or were undergoing rehabilitation because of back pain/sciatica, and the
self-reported return to full-time work at the two-year follow-up was used as the outcome. 
Sample B comprised 125 patients who, according to the NSBR, at the time of their inclusion 
in the study were receiving sickness benefits or a rehabilitation allowance because of back 
pain/sciatica. The outcome was the time to first sustained return to work, defined as the 
number of calendar days from inclusion to the first period of >60 days during which no 
benefits were received from the NSBR.
At the two-year follow-up, approximately 25% of the patients were still out of work. 
In sample A, younger age, better baseline general health, lower sciatica bothersomeness, less 
fear avoidance–work, and a negative straight leg raising test result were significantly 
associated with a higher probability of having returned to full-time work after two years. 
Surgery was not significantly associated with this outcome. In sample B, a previous history of 
sciatica, a duration of the current sciatica episode of > 3 months, higher baseline sciatica 
bothersomeness, higher fear avoidance–work, and greater back pain were significantly 
associated with a longer period before a sustained return to work. Surgery was negatively 
associated with the time to a sustained return to work in both the univariate (hazard ratio 0.60; 
95% CI 0.39–0.93; P = 0.02) and multivariate analyses (hazard ratio 0.49; 95% CI 0.31–0.79; 
P = 0.003).
9 GENERAL DISCUSSION
This thesis demonstrates that patients with sciatica report considerable health problems in 
addition to sciatica-specific symptoms and disability. A number of both generic and sciatica-
specific symptoms were significant prognostic factors for return to work after two years. 
These results also contribute important knowledge about the methodological issues involved 
in the analysis of sciatica.
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The main results will be discussed with respect to the methodological considerations,
including the design, study samples, representativity, the validity of prognostic and outcome 
measures, and statistical methods. Finally, the main results will be compared with other 
currently relevant evidence.
9.1 Methodological aspects
9.1.1 Study designs and general considerations
In this thesis, a multicentre cohort study was used because one of the main goals was to 
investigate prognostic factors112, 125. In cohort studies, the selection of the study subjects and 
their loss to follow-up may create bias116, especially if the loss to follow-up is related to the 
outcome126. However, in the present study, the loss to follow-up was only 12% at one year 
and 18% at two years of follow-up, suggesting that loss to follow-up cannot be considered an 
important source of bias here.
In cross-sectional studies, all the information is collected at the same time, so loss to 
follow-up or recall bias is not a concern. The cross-sectional design is useful in identifying
associations, but cannot be used to decide cause and effect. This limitation should be taken in 
consideration in the interpretation of the studies reported in papers I–III, in which cross-
sectional designs were used.
9.1.2 Study samples and representativity
To optimize the external validity of the prospective cohort, we included a relatively large 
number of patients and used a multicentre design. In general, we consider our patient sample 
to be representative of the patients referred to secondary care with sciatica in the south-east 
region of Norway. The inclusion criteria in the present study were formulated to allow 
patients with paresis but without radicular pain to be included. However, this group turned out 
to be very small, constituting only 1.5% of the total cohort. Other sciatica studies have 
differed on this point. In the Maine Lumbar Spine Study, patients were accepted who “had 
sciatica” according to orthopaedic surgeons or neurosurgeons. In Weber’s studies of the 
effects of piroxicam56 and surgery66 on sciatica, only patients with a positive straight leg
raising test were included. In two trials reported after the start of the present study, Peul127
included patients both with and without a mild neurological deficit, whereas the SPORT 
study128 required a positive nerve-root-tension sign (positive straight leg raising or femoral 
tension sign). The use of different inclusion criteria might have caused differences in the 
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patient samples across these studies, and should be taken into account when comparing our 
result with those of other cohorts.
The response rate in the present study was generally high, and all follow-up rates were 
above 80%, a cut-off commonly used to separate “high quality” from “low quality” studies116, 
126, strengthening the generalizability of our results. The patients who did not respond at the 2 
year follow up were younger, more likely to be smoking, to have a positive straight leg raising 
test, to report more back pain, lower general health and more emotional distress at baseline 
than those who completed the 2 year follow-up. 
A limitation in patient recruitment was the incomplete recording of patients who were 
eligible according to the inclusion/exclusion criteria, but for some reason were either not 
invited or declined to participate. Another minor limitation was that only patients recruited 
from Sykehuset Østfold participated in the test–retest procedure in the validation study (paper 
I). This was because of practical difficulties involved in administering the retest 
questionnaire. However, the main purpose was to include patients across a broad spectrum of 
symptom severity, which was achieved.
A concern in the planning of the method agreement study (paper IV) was the selection 
of the patients who should be included in the analysis of sickness absence duration. We 
decided to include those patients who had had absence according to either self-report or the 
NSBR. If all patients had been included, the difference between the two methods would not 
only result from the disagreement between the two methods but would also have reflected the 
varying numbers of patients without sickness absence in the three recall time periods. 
However, to ensure that the self-report of no absence was checked against the registry, we 
also analysed the occurrence of sickness absence.
To assess the prognostic factors for return to work, only sick-listed patients were 
included in the analysis (paper V). This gave us the opportunity to provide estimates for how 
fast patients returned to full-time work using Cox’s regression. If patients who were working 
at baseline had been included, this analysis would not have been possible. Conversely, if 
working patients had been included, the impact of the baseline sickness absence on the 
probability of return to work at two years could have been assessed. Because two previous 
studies129, 130 found no evidence that workers’ compensation was significantly related to work 
status after two or four years, we considered that issue to be less important when we were 
designing the study reported in paper V.
The second study sample, the general population sample reported in paper III, was 
recruited 2–4 years before the patient cohort sample. This might have caused bias, but 
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previous research has demonstrated that SHC scoring in the general population is remarkably 
stable over time92. However, another potential source of bias concerns the different methods 
with which the SHC questionnaire was administered. In the patient sample, the patients 
described their SHCs in a self-reported questionnaire format, whereas in the general 
population, the SHC data were obtained by computer-assisted telephone interviewing. This 
might have affected the response rates. The response rates for random-digit-dialling sample 
surveys are not quantifiable because the sampling is continuous until the quota is reached. An 
Australian study indicated that 30%–55% of eligible persons responded to a survey of beliefs 
about back health in the general population when this methodology was used131. Random digit
dialling has been shown to be feasible and accurate in other fields of health research132. 
However, no information exists about the non-responders in the present general population 
sample, i.e., those who did not have a telephone, those who did not answer the phone calls,
and those who refused to participate. Therefore, we do not know whether the responders and 
non-responders differed in terms of their SHC scores.
9.1.3 Validity of sciatica-specific outcomes
In the first paper, the translation and cross-cultural adaptation of the sciatica-specific outcome 
measuresthe SBI, the SFI, and the MSBQwere performed according to recent 
guidelines133, and their psychometric properties were tested according to the
recommendations of Terwee et al.134. 
A major issue regarding the internal validity of the MSBQ was the relatively large 
number of patients (4.6%–5.0%) who missed one or more items. The sexual activity item 
alone was not completed by 2.8% of respondents. Missing item rates as high as 15% have
been reported for the original Roland–Morris Disability Questionnaire135. In general, there is 
no agreement in the literature about how to deal with missing items in quality-of-life 
measures. Because our study was the first to use the MSBQ as a free-standing outcome 
measure, no procedure exists yet to handle missing items in the MSBQ. However, for quality-
of-life instruments that are based on unweighted sum scores, it is common to substitute 
missing items with the arithmetic mean of those items that are available. This procedure is 
restricted to cases in which the respondent has completed at least half the items on the 
scale136, 137. However, in the current study, no data were imputed.
The main constructs in the sciatica-specific outcome measures were tested by forming 
a priori hypotheses regarding the relationships between the three measures of interest
measured with established instruments, such as the SF-36110, and pain visual analogue 
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scales138. Because there is no gold standard available for constructs like ‘disability’ and ‘pain 
and symptoms’, testing the construct validity in terms of prespecified hypotheses is the 
recommended method134. However, with respect to construct validity, our results indicated 
that the patients did not distinguish between symptom bothersomeness and symptom 
frequency. In most aspects of the validation process, the results of the SBI and SFI were very 
similar. The use of both questionnaires did not seem to yield more information than the use of 
one. This is consistent with previous research in which the results of both measures have been 
reported43, 73, 139, 140.
The validation process also revealed an interesting point regarding the importance of 
the scoring formats of these scales. The SFI categories are labelled: not at all, very rarely, a
few times, about half the time, usually, almost always, and always. The SBI categories have 
category labels: 0 (not bothersome), 3 (somewhat bothersome), and 6 (extremely bothersome). 
On the SFI, patients avoided the middle response category about half the time, whereas on the 
SBI, there was no corresponding avoidance of the middle response category. There are 
different opinions in the literature on the use of an odd number of categories for a 
symmetrical scale. The middle category usually represents a “don’t know” alternative, and 
some argue that it is better to have an even number of categories so that the respondents must 
make a choice136. There are concerns about treating ordered categorical scales as if they are 
true interval scales, because one cannot know if the size of the difference, say between not at 
all and very rarely, is identical to the size of the difference between usually and almost
always. This may represent a potential weakness of the SFI.
We also investigated the test–retest properties using several recommended methods116, 
134. In general, the test–retest reliability was moderate to good, independent of the method 
used. To ensure an adequate sample size, we included 87 patients. No general rules for the 
appropriate sample sizes for test–retest studies exist, but n > 50 has been suggested116, 134. We 
also chose to use a test–retest interval of two days, assuming that this would be long enough 
for the patients to forget their earlier responses. Another method is to select patients who,
after a period of follow-up, state that their condition has not changed and compare their score 
values at the first and second occasions. Atlas44 used a time interval of three months when 
evaluating the MSBQ. With such a long recall interval, it is difficult to know how much error 
is caused by the measure and how much is recall error.
In this study, responsiveness was investigated with both a distribution-based
approach, using statistical distributions, and an anchor-based approach141, using an external 
criterion by which the change in the measure under study is compared. An example of a 
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distribution-based method is when the change is related to the minimal detectable change
(paper I). When a change is larger than the minimal detectable change, one can assume, with 
95% confidence that a real change has occurred. We used two anchor-based approaches, one 
retrospective and one prospective. The retrospective anchor was the patient’s rating on a 
global change scale at the three-month follow-up. However, the method of using a 
retrospective external criterion, although very common in the literature, has been criticized. 
Norman142 claimed that this implies that we accept that a single-item global rating is superior 
to the multi-item measure under study. If this is true, it would be reasonable to use the global 
change scale rather than the new measure. Furthermore, the correlated measurement error 
between the global rating and the new measure is likely to inflate the true association between 
them. It is also likely that patients have difficulty recalling their initial state on which the 
estimate of change is based. Therefore, we also created a prognostic anchor, which would be 
independent of the patient’s ratings. Based on reports in the literature indicating greater short-
term improvement after surgical treatment than after non-surgical treatment, a criterion was 
created according to whether or not the patients underwent surgery between baseline and three
months.
Among a large number of available measures of responsiveness, we chose to calculate 
the standardized response mean and the area under the  receiver operating characteristic
curve143, 144. After the papers of the present study were published, an expert Delphi panel145, 
146 gave a consensus statement on the taxonomy, terminology, and definitions of measurement 
properties for health-related patient-reported outcomes (PRO). The methods used in our study 
are generally consistent with the recommendations of the experts. However, in assessing 
responsiveness, the Delphi panel considers the use of effect sizes inappropriate, including the 
standardized response mean. They argue that effect sizes represent measures of the magnitude 
of change attributable to an intervention or other event, rather than measures of the quality of 
the measurement instrument itself. The panel recommends using the same method to assess 
responsiveness as is used to assess construct validity by testing prespecified hypotheses about 
the relationships of the changes in the questionnaires to the changes in other measures.
We also determined the minimal important change, which has been defined as the 
smallest difference in an instrument’s score that patients perceive as beneficial or which 
would mandate a change in the patient’s management147. In the literature, the terms ‘minimal 
clinically important difference’ (MCID) and ‘minimal clinically important change’ (MCIC)
are used interchangeably with the minimal important change. Because we did not expect 
many patients to become worse between baseline and three months, no minimal important 
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change addressing deterioration was defined. Therefore, in the present study, the most 
accurate meaning is the minimal important improvement.
9.1.4 Validity of the Subjective Health Complaints Inventory
In the literature, there is no consensus regarding the definition of the term ‘comorbidity’. In 
the present study, we used Feinstein’s definition as “coexisting ailments to an index 
disease”148, but several others exist. A review identified 13 different methods to assess 
comorbidity149, from counting the number of coexisting diseases or the ICD-9 codes150, to 
counting those conditions that have required treatment or have altered organ function151. 
Comorbidity has been assessed with interviews, questionnaires, physical examination, 
medical chart reviews, and coded databases149.
The main reason for using the Subjective Health Complaints Inventory in the present 
study was that when the study was planned, it was the only self-reported comorbidity 
instrument that had been used in a Norwegian population. Furthermore, in co-operation with 
one of the authors of paper III, Camilla Ihlebæk, we had access to a data set that allowed us to 
compare the sciatica cohort directly with a general population sample.
The Subjective Health Complaints Inventory has been used in various populations and 
settings152-156. A disadvantage of it is that its psychometric properties, such as its test–retest 
and construct validity, have not been properly assessed. According to the authors who 
developed the inventory, their objective was to create an instrument that was able “to score 
subjective health complaints as they occur in the normal working population, without 
diagnoses, hypotheses or attributions”93. The selection of items was “not based on any 
specific theory and should cover the most frequent health concerns and reasons for encounter 
with a general practitioner.” The authors do not state whether the selection of symptoms was
based on prevalence estimates of all the symptoms that occur in primary care, so we cannot 
know the percentage of the complaints presented to a general practitioner that are covered by 
the inventory. Nor was the reason for the inclusion of each item specified. Another symptom 
list in current use, the Personal Health Questionnaire-15, was constructed to cover 90% of 
physical complaints reported in an outpatient setting157. Recently, it has been shown that 
general practitioners categorize 21% of these physical symptoms as medically explained, 37% 
as medically unexplained and 41% as neither fully explained or non-explained158.
Many of the SHC items represent medically unexplained somatic symptoms or 
functional somatic symptoms that are commonly used to screen for somatization157. Eleven of 
the 20 symptoms in the somatization disorder criteria list of the Diagnostic and Statistical 
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Manual of Mental Disorders IV are also found in the Subjective Health Complaints Inventory, 
whereas cold/flu, cough/bronchitis, asthma, eczema, and allergy are generally not regarded as 
medically unexplained somatic symptoms. A self-administered measure cannot distinguish 
between medically explained and unexplained symptoms, a distinction that requires a directed 
interview and clinical judgment. Therefore, in this study, we regarded the SHC scores to 
represent both medically explained and unexplained symptoms.
In the present study, the respondents were asked to grade the intensity of each SHC
item experienced in the preceding month on a four-point scale: not at all (0), a little (1), some
(2), and severe (3). To compare the occurrence of complaints in the sciatica patient sample
and the population sample with logistic regression, the responses were categorized into absent
(0) or present (1, 2, or 3). Dichotomizing complaints into present or absent may create bias 
because information regarding severity is lost. It can also be argued that complaints with a
little intensity are clinically irrelevant, and a cut-off at some intensity would be more 
appropriate. However, previous clinical samples159, 160 showed strong associations between 
the ORs for any complaints (score > 1) and substantial complaints (score > 2). In the 
reference population, the correlation coefficient between any complaints and substantial
complaints was 0.81. Dichotomizing the scores into absent or present and summing the 
number of SHC items present made it possible to compare the patients’ SHC scores with 
those of the general population sample, and between baseline and the one-year follow-up. 
However, because some of the SHC items overlap, summing the items from the Subjective 
Health Complaints Inventory may be methodologically disputable. For example, a person 
with gastric symptoms will report several possible complaints: ‘stomach discomfort’, 
‘heartburn’, ‘ulcer/non-ulcer dyspepsia’, and ‘stomach pain’, resulting in an SHC score of 4, 
whereas a person bothered with hot flushes would only have a score of 1.
Compared with the general population sample, the adjusted ORs for the sciatica 
patients reporting any SHC were significantly elevated for 15 of the 27 SHC items. 
Statistically, we expected that 5% (i.e., 1–2 items) would be elevated by chance. 
Consequently, the high number of elevated ORs cannot be explained by the high number of 
analyses performed.
9.1.5 Validity of sickness absence
In the present study, the public registry (NSBR) was regarded as the reference standard. In 
assessing the agreement in the duration of sickness absence, we calculated the 95% limits of 
agreement and presented a chart in which the differences between the self-report and registry
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data were plotted against the registry data. Bland114 has recommended that in studies where 
the true value is unknown, the difference between the measurements produced for each 
subject with the two methods should be plotted against their mean. Because we used the 
registry data as the reference standard in the present study, we chose to plot the differences 
against the registry values. The 95% limits of agreement were calculated as described 
previously, handling the measurements made with each method as the test–retest 
measurements were handled in paper I.
No formal validation of the accuracy of the NSBR data has previously been 
performed. The NSBR data constitute the basis for the payment of sickness benefits and are 
generally regarded as accurate, but this does not imply that they are free of error. The lack of
knowledge about how well the NSBR register data agree with the sickness certificates and the 
actual presence at work is a limitation of the present study.
A number of methodological challenges exist in the self-report of sickness absence. In 
Norway, an individual may be listed to participate in rehabilitation in the work-place, making 
it complicated for the individual to know whether he or she is formally sick-listed or working. 
The same may apply to periods of parental leave and vacation16. Patients may also have more 
than one place of employment and only be sick-listed for one of them, or retired pensioners 
may have a part-time job. For practical reasons, the respondents in this study were classified 
as having had sickness absence if they were registered by the NSBR, regardless of whether 
their sick leave was partial or complete. We did not have access to NSBR data regarding the 
percentage of partial sickness absence. Therefore, our analyses were performed without 
differentiating between those with low and those with high sickness absence percentages, 
assuming that the degree of sickness absence would not influence the validity of the self-
report. This assumption does not necessarily hold true; an individual who is on complete sick 
leave and staying at home may be more aware of his or her sickness absence status than 
someone who is on partial sick leave and working six in eight hours every day.
Another potential source of error lies in the validity of the diagnoses on the sickness 
absence certificates. In planning the study, we decided only to ask the patients for permission 
to obtain registry data regarding their back pain/sciatica. Therefore, only absences with the 
diagnostic code for back pain or sciatica were available for analysis. Because the diagnoses on 
sickness certificates are generally written for administrative purposes, little is known of how 
well they reflect the actual clinical conditions of the patients161.
9.1.6 The prognostic analyses
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In paper V, we used the definition of removal from the NSBR sick list as a proxy for patients 
having returned to full-time work. Removal from the list implies receiving no financial 
support from the NSBR. No documentation of this assumption exists, but in our opinion, it is 
a very creditable assumption. In Norway, individuals who have received short-term benefits 
will also be entitled to long-term benefits if their disease persists, so removal from the list 
indicates a return to work. The NSBR sick list does not include people on retirement 
pensions, so anyone who reported being an old-age pensioner at the two-year follow-up was
excluded from the analyses. Those who reported being a student or homemaker were also 
excluded.
The selection of potential prognostic factors in paper V was based on a broad
perspective, by including variables reflecting demographic, psychological, and social factors,
in addition to clinical examination findings. A limitation of the present study was that work-
related variables were not included. Previous research has indicated that several work-related 
variables, including job demands, control, strain, and flexibility, are important factors in
returning to work14, 15, 81.
Multivariate logistic regression and Cox’s proportional hazard regression analyses are 
generally considered the most suitable methods for investigating the potential prognostic 
factors for an outcome15. Various authors have suggested that in multiple logistic regression 
and proportional hazard analyses, at least 10 events are required for each independent 
variable112, 118. However, Vittinghoff162 showed that 5–9 events may be acceptable. In paper 
V, Cox’s regression was performed with eight events per variable and logistic regression with 
nine events per variable.
9.2 Main results compared with other published studies
9.2.1 Symptom self-report
The self-report of symptoms assessed with the Norwegian versions of the SBI and SFI and the 
self-report of disability assessed with the Norwegian version of the MSBQ were found to be 
acceptable for patients with sciatica, and overall, the psychometric properties were good. 
Several sciatica studies have been performed with non-specific back-pain-related disability 
measures, including the original Roland–Morris Disability Questionnaire or the Oswestry 
Disability Index as the primary outcome measures59, 140. A potential limitation of our study 
was that the sciatica-specific measures were not compared with these commonly used back-
specific measures. Therefore, we cannot say whether there are any advantages in using 
sciatica-specific measures compared with standard back-pain outcome measures. A key issue 
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here is how the different measures handle radicular symptoms compared with back pain. For 
instance, the Oswestry Disability Index does not distinguish between back and radicular 
symptoms but simply examines perceived function. The sciatica indices partly incorporate 
back pain in one of the four items by asking about back or leg pain while sitting. Because 
sitting entails stretching the L5 and S1 nerve roots, that item is probably intended to measure 
radiculopathy. However, back pain is important in sciatica. At baseline, the patients’ mean 
score on the back pain visual analogue scale was 43, whereas the mean leg pain score was 63. 
Further studies must be undertaken to assess whether the weighting of back pain in the 
sciatica indices is appropriate.
To our knowledge, the present study is the first to investigate self-reported 
paraesthesia and weakness in patients with sciatica, and consequently our results in paper II
are difficult to compare with the existing literature. Based on previous research, it is not 
surprising that women rated the severity of their leg pain higher than men163, 164. Our results
also demonstrate a sex difference in the self-report of paraesthesia and weakness. The clinical 
examination findings were weakly associated with symptom severity; for instance, muscular 
paresis explained only 19% of the variability in self-reported weakness, and sensory findings 
only 10% of the variability in paraesthesia. The associations between the symptoms and the 
clinical test results warrant further exploration.
9.2.2 Comorbidity
Our results in paper III show that patients with sciatica reported a higher mean SHC score
than the general population. Except for a Finnish population study54 that showed weak 
associations between sciatica and cardio-vascular, respiratory, mental, and some 
musculoskeletal conditions, we are not aware of other comorbidity studies of sciatica. 
Consequently, it is difficult to relate our findings to the existing literature. The high 
occurrence of anxiety and depression are consistent with previous research showing strong 
associations between pain and emotional distress165-168 and between depression and physical
illness in general169, 170.
The mean score for SHCs reported by the sciatica patients at baseline (7.5 [SD 4.5]) 
closely resembles the mean score recently reported by patients with chronic non-specific low 
back pain (7.6 [ 4.5])171 when the same methodology was used. In another Norwegian study 
of low back pain159, patients who had been sick-listed for 8–12 weeks reported seven of the 
27 SHCs more frequently than a reference population, as compared with 17 in the sciatica 
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cohort at baseline. These two studies suggest that there are no important differences between 
specific and non-specific back pain in terms of comorbid SHCs.
The very high odds for reporting SHCs among those who at the 1 year follow-up had 
unchanged or worse sciatica are comparable to those reported by patients with chronic 
whiplash-associated disorders153 or irritable bowel syndrome160. This suggests that a high 
prevalence of comorbidity is not confined to conditions regarded as unexplained or 
functional. The reduction in the SHC scores to normal levels in those who recovered fully
from their sciatica might imply that comorbidity in this patient group is a phenomenon 
secondary to pain and disability. Interestingly, the SHC scores at the time of inclusion in the 
cohort varied according to how the patients reported the outcome of their sciatica one year 
later. Those who stated that they had recovered at the one-year follow-up reported lower SHC
scores at baseline than those of patients who stated that they were a little better, unchanged, or 
worse at the one-year follow-up. These results are consistent with the prospective analysis of
the current cohort by Haugen et al. (submitted), who found that higher SHC scores at baseline
significantly increased the probability of an unsuccessful clinical outcome at one and two
years. However, the multivariate analysis reported in paper V showed that increasing SHC 
scores did not predict the return to work or the duration of sickness absence. Unfortunately, 
no other longitudinal studies of this subject exist.
SHC items such as cold/flu, cough/bronchitis, asthma, and eczema did not seem to be 
affected by sciatica. These items were not more prevalent in the total cohort at baseline, or
their ORs elevated in the unchanged or worse group at the one-year follow-up, compared with 
the general population sample. This is consistent with Hagen’s findings in patients with low 
back pain159.
More prospective studies are required to increase our knowledge of the mechanism 
involved and how health complaints are formed and evolve. Such studies should especially 
focus on the early stages of pain.
9.2.3 Sickness absence according to self-report data and registry data
The main finding reported in paper IV was that the precision of the self-reported duration of 
sickness absence was poor, whereas the self-reported occurrence of sickness absence was 
acceptable. Several investigators have reported results based on the self-report of sickness 
absence without discussing the validity of their data80, 172, 173. As might be expected, the 
agreement between the self-reported and registry data was better for the occurrence of 
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sickness absence than for the duration, but dichotomized occurrence data are obviously less 
useful.
Our results commend caution in using self-reported duration of sickness absence in 
research. However, our results must be replicated before they can be generalized to other 
settings or samples. Because the definitions, procedures, and legislative rules of sickness 
absence vary between countries, the validity of the self-report of sickness absence may need 
to be established in each country of interest.
9.2.4 Prognostic factors for sickness absence and return to work
At the two-year follow-up, approximately 75% of the patients who were sick-listed or on 
rehabilitation at baseline had returned to full-time work, which is consistent with previous 
research74. Previous studies of the prognostic factors for return to work in sciatica patients 
have focused on the effect of the baseline compensation status of the patients, without finding 
this factor to be significantly related to the outcomes at two or four years of follow-up74, 129.
At the four-year follow-up in the Maine Lumbar Spine Study, younger age, better self-
perception of general health, and less severe low back pain at baseline were associated with 
higher return to work rates74. Although our results are restricted to a two-year follow-up
period, they confirm those findings and add further potential prognostic factors: A negative
straight leg raising test, lower bothersomeness of sciatica at baseline, less fear avoidance–
work, a shorter history of sciatica, and a duration of the current episode of < 3 months
predicted a faster return to work or a higher return to work rate.
The finding that surgical therapy was significantly associated with a slower return to 
work was surprising, although the lack of a positive association between surgery and return to 
work has also been reported by others. In a randomized controlled trial that compared early 
surgery with prolonged conservative care, van den Hout174 reported increased absenteeism 
from work immediately after surgery but no significant differences in sickness absence 
between the groups from baseline to one year. In both the observational and randomized 
SPORT trials72, 73, surgery was not significantly related to self-reported return to work at two 
years and the same was found at the four-year follow-up in the Maine Study74. The 
mechanism underlying why surgery leads to a slower return to work is difficult to explain, 
especially because surgery has been associated with a more rapid recovery from sciatica72, 73, 
113. The prospective analysis of the current cohort by Haugen et al. showed that surgical 
treatment was significantly associated with self-reported recovery after one year, but not at 
the two-year follow-up (Haugen et al., submitted).
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The present study also found that the straight leg raising test, the SBI, and back pain
remained significantly associated with return to work in the final multivariate models. These 
results are similar to the results of Schade et al.76 who found that preoperative pain levels in 
surgical patients predicted self-reported return to work two years after the operation. The 
results of a Finnish study of surgical patients80 also indicated that the leg pain and pain-related 
disability reported after the operation were related to the number of self-reported sickness 
absences. Consistent with the Maine Lumbar Spine study74, findings of abnormal motor or 
sensory functions were not associated with return to work in.the present study.
Our study is the first to report the role of fear avoidance beliefs in sciatica, suggesting 
a negative association with return to work. A systematic review175 of studies of low back pain 
provided no evidence of fear avoidance as a strong risk factor for poor outcomes, including 
occupational disability. However, previous authors have usually not distinguished between 
fear avoidance for work and fear of movement. In the present study, fear of movement/re-
injury was not significantly associated with return to work in the multivariate analysis. It is 
possible that fear avoidance–work functions as a proxy for work-place-related factors. In a 
study of workers with musculoskeletal disorders, Løtters176 reported that the prognostic value 
of fear avoidance on compensation benefits was no longer significant when work-related 
variables were included in the multivariate model.
Other potential prognostic factors such as level of education, smoking, self reported 
comorbidity and emotional distress were not significantly associated with return to work in 
our final multivariate models. There is a well known association beteween educational 
attainment and general health177, 178, but education has not been consistently associated with 
return to work in low back pain14, 15or other health conditions179, 180. However, a few studies 
on surgically treated sciatica patients indicated lower education levels to be associated with 
less return to work78. Moreover, although higher levels of self-reported comorbidity was 
significantly associated with a non-successful clinical outcome in the study of Haugen et al 
(submitted), it was not significantly associated with return to work. Since the literature on the 
prognostic ability of self reported comorbidity on work related outcomes is sparse, it is 
difficult to compare our findings with other current relevant evidence. Similarly, emotional 
distress did not remain in the multivariate models. This finding is opposite to two previous 
studies on surgical treated sciatica patients, which found that depression was associated with 
work capacity at 1 year79and with return to work at 2 years76.
Because of the differences in definitions, procedures, and legislative rules relating to
sickness absence across countries, comparisons with other studies should be done with 
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caution. Most of the findings in the present study must also be replicated by others before 
they can have direct implications for clinical practice.
10 CLINICAL IMPLICATIONS AND FURTHER RESEARCH
Validated questionnaires are not yet commonly used in daily clinical work among patients 
with sciatica. The present study has provided Norwegian versions of sciatica-specific 
measures of symptoms and disability, which are now ready for use. The effects of introducing 
these measures into the clinical context should be investigated, especially to determine
whether their use leads to changes in patient care.
Another issue is the validity of self-reported weakness in sciatica. In the present study,
a clinical finding of muscular paresis, scored as present or absent, only explained one-fifth of 
the variability in self-reported weakness. The agreement between self-report and a clinical 
examination requires further scrutiny. This should be done by relating self-report to a more 
detailed and graded clinical scoring procedure than was used in this study.
Among the studies of comorbidity in back pain, the present study is the first to use a 
prospective rather than a cross-sectional design. To extend our knowledge of the mechanism 
involved and how health complaints are formed and evolve, more prospective studies are 
required. Such studies should especially focus on the early stages of pain.
More research is also required on the topic of using self-reported sickness absence 
duration data in research rather than registry data. Because of differences in the definitions, 
procedures, and legislative rules relating to sickness absence across countries, the results 
should be compared with caution.
Caution must also be exercised in implementing the prognostic factors for 
occupational disability until our findings have been replicated in other studies. The prognostic 
capacity of work-related characteristics should be investigated, especially if such factors 
modify the effects of fear avoidance beliefs regarding work. The next step in this research will 
be to test whether interventions targeted at prognostic factors can prevent prolonged sickness 
absence or delayed return to work in patients with sciatica.
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11 CONCLUSIONS
 The Norwegian versions of the Maine–Seattle Back Questionnaire, the Sciatica 
Frequency Index, and the Sciatic Bothersomeness Index were rapidly administered, 
with acceptable internal consistency, test–retest reliability, measurement error, 
construct validity, and responsiveness.
 The patients rated leg pain as their most bothersome symptom, followed by 
paraesthesia and weakness. Men reported lower symptom scores than women.
 Patients with sciatica caused by lumbar disc herniation reported significantly more 
health complaints than the normal population. At the one-year follow-up, the number 
of complaints decreased to normal levels among those who had fully recovered. In 
patients with persistent or worsened sciatica, the number of health complaints 
increased to almost double that in the general population.
 The agreement between self-reported data and data from a public registry regarding 
the duration of sickness absence was poor for a recall period of three months, and 
became worse as the length of the recall period increased. The use of self-reported 
data on the duration of sickness absence may severely reduce the statistical power of 
clinical trials and the accuracy of cost estimates for sickness absence in sciatica 
patients. The agreement on the occurrence of sickness absence was generally good.
 Twenty-five per cent of patients who were sick-listed at baseline were still away from
work at the two-year follow-up. The baseline factors positively associated with return 
to work were younger age, better self-perceived general health, less bothersomeness of 
sciatica, fewer fear avoidance beliefs regarding work, less back pain, fewer previous 
sciatica episodes, a shorter duration of the current episode, and a negative straight leg
raising test. Surgical treatment was associated with a slower return to work.
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13 APPENDIX
The Norwegian version of the Maine Seatlle back questionnaire
Når du har vondt i ryggen eller benet (isjias) kan det være vanskelig å gjøre noen av de 
tingene du vanligvis gjør. Her er noen setninger folk har brukt for å beskrive seg selv når de 
har ryggsmerter eller isjias. Når du leser dem kan det være at noen av dem skiller seg ut fordi 
de beskriver deg i dag. Når du leser en setning som beskriver deg i dag, sett ett kryss for ja i 
boksen til høyre, hvis ikke setningen passer så kryss av i nei-boksen.
Jeg skifter stilling ofte for å forsøke å gjøre det behagelig for ryggen 
eller benet 
(isjias)………………………………………………………..  	
På grunn av ryggen eller benet (isjias) bruker jeg gelenderet for å gå 
opp trapper……………………………………………………………...  	
På grunn av ryggen eller benet (isjias) kler jeg på meg saktere enn 
vanlig……………………………………………………………….  	
På grunn av ryggen eller benet (isjias) står jeg oppreist bare i korte 
stunder av gangen……………………………………………………..  	
På grunn av ryggen eller benet (isjias) forsøker jeg å la være å bøye 
meg eller sette meg på 
kne………………………………………………  	
På grunn av ryggen eller benet (isjias) synes jeg det er vanskelig å reise 
meg fra en stol…………………………………………………………..  	
Jeg har vondt i ryggen eller benet nesten hele tiden…………………….  	
På grunn av ryggen eller benet (isjias) sover jeg 
dårligere……………...  	
På grunn av ryggen eller benet (isjias) holder jeg for det meste sengen..  	
På grunn av ryggen eller benet (isjias) har min seksuelle aktivitet avtatt  	
Jeg pleier å gni eller holde på de stedene på kroppen som gjør vondt 
eller er 
ubehagelige……………………………………………………...  	
På grunn av ryggen eller benet (isjias) gjør jeg mindre av det daglige 
arbeidet i huset enn jeg vanligvis ville gjort…………………………….  	
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The Norwegian versions of the Sciatica Bothersomeness Index (A) and the Sciatica 
FrequencyIndex (B)
(A) I løpet av DEN SISTE UKEN, hvor ofte har du hatt hvert av de følgende symptomene.
Sett ett kryss for hvert spørsmål i den ruten du synes passer best.
Symptomer
Ikke i 
det hele 
tatt
Svært 
sjelden
Noen
ganger
Omtrent 
halve 
tiden
Ofte
Nesten
hele 
tiden
Hele 
tiden
1. Smerter i korsryggen       
2. Smerter i benet (isjias)       
3. Nummenhet eller prikking i benet,
foten eller lysken
      
4. Nedsatt kraft i benet eller foten (f.eks. 
vansker med å løfte foten)
      
5. Smerter i ryggen eller benet når du sitter       
(B) DEN SISTE UKEN, hvor plagsomme har symptomene vært?
For hvert spørsmål, sett en ring rundt tallet som passer best
Symptomer
Ikke 
plagsomme
Noe 
plagsomme
Ekstremt 
plagsomme
1. Smerter i korsryggen 0 1 2 3 4 5 6
2. Smerter i benet (isjias) 0 1 2 3 4 5 6
3. Nummenhet eller prikking i 
benet, foten eller lysken 0 1 2 3 4 5 6
4. Nedsatt kraft i benet eller foten 
(f.eks. vansker med å løfte 
foten) 0 1 2 3 4 5 6
5. Smerter i ryggen eller benet 
når du sitter 0 1 2 3 4 5 6
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The Subjective Health Complaints Inventory
Helseproblemer siste 30 døgn
Nedenfor nevnes noen alminnelige helseproblemer Vi vil be deg om å vurdere hvert 
enkelt problem/symptom, og oppgi i hvilken grad du har vært plaget av dette i 
løpet av de siste tretti døgn. (Sett ring rundt tallet som passer)
Ikke
plaget
Litt
plaget
Endel
plaget
Alvorlig
plaget
1. Forkjølelse, influensa ................ 0 1 2 3
2. Hoste, bronkitt .......................... 0 1 2 3
3. Astma ....................................... 0 1 2 3
4. Hodepine .................................. 0 1 2 3
5. Nakkesmerter............................ 0 1 2 3
6. Smerter øverst i ryggen ............. 0 1 2 3
7. Smerter i korsrygg .................... 0 1 2 3
8. Smerter i armer ......................... 0 1 2 3
9. Smerter i skuldre....................... 0 1 2 3
10. Migrene .................................... 0 1 2 3
11. Hjertebank, ekstraslag ............... 0 1 2 3
12. Brystsmerter ............................. 0 1 2 3
13. Pustevansker ............................. 0 1 2 3
14. Smerter i føttene ved anstrengelser 0 1 2 3
15. Sure oppstøt, «halsbrann» ......... 0 1 2 3
16. Sug eller svie i magen ............... 0 1 2 3
17. Magekatarr, magesår................. 0 1 2 3
18. Mageknip.................................. 0 1 2 3
19. «Luftplager» ............................. 0 1 2 3
20. Løs avføring, diaré .................... 0 1 2 3
21. Forstoppelse.............................. 0 1 2 3
22. Eksem....................................... 0 1 2 3
23. Allergi ...................................... 0 1 2 3
24. Hetetokter ................................. 0 1 2 3
25. Søvnproblemer.......................... 0 1 2 3
26. Tretthet ..................................... 0 1 2 3
27. Svimmelhet............................... 0 1 2 3
28. Angst ........................................ 0 1 2 3
29. Nedtrykt, depresjon................... 0 1 2 3
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